Events Partner Content STING & TLR Targeting Therapies Summit Investigating the cGAS-STING and TLR pathways
Views & Analysis CAR-Ts dominated the agenda at ASH 2017 The American Society for Hematology congress was dominated by CAR-T therapies – their potential new uses, how to manage safety issues and bring these costly cellular treatments to patients.
Partner Content Partner Content Exclusive Pfizer Speaker Interview Released Exclusive Pfizer Speaker Interview Released
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
